Year-Long test for dementia psychosis drug continues

NCT ID NCT07095465

ENROLLING_BY_INVITATION Disease control Sponsor: ACADIA Pharmaceuticals Inc. Source: ClinicalTrials.gov ↗

Summary

This study continues testing ACP-204 for psychosis symptoms in people with Lewy body dementia for one full year. It's for 126 patients who already completed the previous trial and want to keep taking the medication. The main goal is to check how safe the drug is over the long term and what side effects might occur.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Advanced Clinical Research Network, Corp

Miami, Florida, 33135, United States
Hawaii Pacific Neuroscience

Honolulu, Hawaii, 96817, United States
Health Synergy Clinical Research, LLC

West Palm Beach, Florida, 33407, United States
Homestead Associates in Research Inc

Miami, Florida, 33032, United States
Humanity Clinical Research, Corp

Aventura, Florida, 33180, United States
K2 Summit Research

Lady Lake, Florida, 32159, United States
MediClear Medical & Research Center, Inc.

Miami, Florida, 33165, United States
R and H Clinical Research

Stafford, Texas, 77477, United States
The Movement Disorder Clinic of Oklahoma

Tulsa, Oklahoma, 74136, United States
The Ohio State University, Energy Advancement and Innovation Center

Columbus, Ohio, 43210, United States
University of Kansas Medical Center Research Institute Inc.

Kansas City, Kansas, 66160, United States

Conditions

Explore the condition pages connected to this study.

LEWY BODY DEMENTIA PSYCHOSIS